No abstract available
Keywords:
ibrutinib; phagocytosis; rituximab-dependent.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / pharmacology*
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Cytophagocytosis / immunology*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
-
Macrophages / drug effects*
-
Macrophages / immunology*
-
Rituximab
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab